Abstract Body

Background:

Human Endogenous Retroviruses (HERVs) comprise 8% of the modern human genome and their dysregulated expression is linked to inflammation. Aberrant HERV expression was recognized in adult patients with Crohn’s Disease (CD). We aimed to investigate the expression of HERVs in the ileal mucosa of children with CD compared to healthy children and its correlation to the expression of genes involved in mucosal inflammation.

Methods:

We used online available high throughput RNA-sequencing data of ileal biopsies of 26 children with CD and of 8 age-matched healthy controls. We used Bowtie2 for the alignment of these data against the hg19 human genome assembly; we used Samtools and Bedtools to retrieve read counts corresponding to 13 HERV families (HERV-H, HERV-W, HERV-L, HERV-E, HERV-I, HERV-9, HERV-FRD, HML-1/2/3/4/5/6) and a panel of 20 mucosal immunity genes. We evaluated HERV expression at a family level by summing the reads corresponding to each HERV family. HERV and immunity gene expression was normalized by means of four housekeeping genes (SDHA, HPRT1, RBX1, RRAGA). Normalized expressions were ln-transformed and we used independent sample t-tests, to compare the expression of HERV families and immunity genes in the ileal biopsies of children with CD and controls. Spearman’s rho correlation coefficient was used to identify correlations between the expression of differentially expressed HERVs and immunity genes.

Results:

We recognized upregulated expression of HERV-FRD (1.54-fold, p=0.031) and downregulated expression of HERV-9 (0.52-fold, p=0.013) in children with CD. Of the examined immunity genes, we found significant upregulation in the expression of CXCL-10 (5.9-fold, p< 0.001), CXCL-11 (4.3-fold, p=0.001), CXCL-16 (1.64-fold, p=0.002), SPAK (1.4-fold, p=0.014), ADAM-10 (1.5-fold, p=0.047), TLR-4 (2.1-fold, p=0.036) in CD. HERV-FRD expression correlated to the expression of SPAK (Rho=0.68, p< 0.001) and ADAM-10 (Rho=0.411, p=0.037), while HERV-9 expression correlated to the expression of CXCL-10 (Rho=-0.496, p=0.001), CXCL-11 (Rho=-0.5, p=0.009) and TLR-4 (Rho=-0.5, p=0.008).

Conclusions:

We recognized dysregulated expression of HERV-FRD and HERV-9 in children with CD, correlated to the expression of genes involved in proinflammatory processes in ileal mucosa and the perpetuation of mucosal inflammation. These findings merit further research on the HERV role in intestinal mucosa fitness to confirm the HERV involvement in pediatric IBD.